We've been saying every year for the last 3 "by the end of the year the SP will be x amount". I hope they pump the PR as it's been lack lustre far too long. If the story isn't getting the attention- change tact.
DT has stated two problems:
1/ The problem is Aussies don't know how to value a biotech company.
2/ There's a lack of liquidity.
What on earth are they doing to resolve it? The rubbish SP and valuation needs a boot. These same issues have been here for over 3years
RAC - Charts & Price Action, page-21603
-
- There are more pages in this discussion • 359 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
